View Latest Medical and Pharma Bids and Tenders

Medicines Containing The Active Ingredient Rituximab - In The Dosage Form Concentrate For Infusion Solution (Atc: L01Fa01)

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Tocilizumab (Excl. Infusion Solution Concentrate), Atc L04Ac07 (Obo) For The Period 01.10.2024 - 30.11.2025

Bidding For The Purchase Of Medical Supplies, Sodium Chloride 900 Mg/100 Ml Solution For Infusion, 100 Ml Bag, By Electronic Bidding.

Tender For Purchase Of Dextrose 5 G/100 Ml Solution For Injection/Infusion, 100 Ml Bag By Electronic Bidding Method.

Bidding For The Purchase Of Human Serum Albumin 5 G/100 Ml Solution For Infusion, 250 Ml Vial By Electronic Bidding.

Bidding For The Purchase Of Amino Acids 3 G/100 Ml + Dextrose 7.5 G/100 Ml Solution For Infusion, 1 L Bag By Electronic Bidding.

Bidding For The Purchase Of Medical Supplies Sodium Chloride 900 Mg/100 Ml Solution For Injection/Infusion, 100 Ml By Electronic Bidding.

Bidding For The Purchase Of Alteplase 50 Mg Powder And Solvent For Solution For Injection Infusion By Electronic Bidding.

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab (Exclusively In The Dafo Infusion Solution Concentrate), Atc L04Aa23 For The Period December 1St, 2023-November 30Th, 2025

Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Natalizumab (Exclusively In The Dafo Infusion Solution Concentrate), Atc L04Aa23 For The Period December 1St, 2023-November 30Th, 2025